The neonate versus adult mammalian immune system in cardiac repair and regeneration by Sattler, S & Rosenthal, N
  	

The neonate versus adult mammalian immune system in cardiac repair and
regeneration
Susanne Sattler, Nadia Rosenthal
PII: S0167-4889(16)30001-5
DOI: doi: 10.1016/j.bbamcr.2016.01.011
Reference: BBAMCR 17781
To appear in: BBA - Molecular Cell Research
Received date: 7 September 2015
Revised date: 17 December 2015
Accepted date: 18 January 2016
Please cite this article as: Susanne Sattler, Nadia Rosenthal, The neonate versus adult
mammalian immune system in cardiac repair and regeneration, BBA - Molecular Cell
Research (2016), doi: 10.1016/j.bbamcr.2016.01.011
This is a PDF ﬁle of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its ﬁnal form. Please note that during the production process
errors may be discovered which could aﬀect the content, and all legal disclaimers that
apply to the journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
The Mammalian Immune System in Cardiac Repair and Regeneration  Susanne Sattler & Nadia Rosenthal 
   1/32 
The neonate versus adult mammalian immune system in cardiac repair and 
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Abstract 
The immune system is a crucial player in tissue homeostasis and wound 
healing. A sophisticated cascade of events triggered upon injury ensures 
protection from infection and initiates and orchestrates healing. While the 
neonatal mammal can readily regenerate damaged tissues, adult regenerative 
capacity is limited to specific tissue types, and in organs such as the heart, 
adult wound healing results in fibrotic repair and loss of function. Growing 
evidence suggests that the immune system greatly influences the balance 
between regeneration and fibrotic repair. The neonate mammalian immune 
system has impaired pro-inflammatory function, is prone to T-helper type 2 
responses and has an immature adaptive immune system skewed towards 
regulatory T cells. While these characteristics make infants susceptible to 
infection and prone to allergies, it may also provide an immunological 
environment permissive of regeneration.  
In this review we will give a comprehensive overview of the immune cells 
involved in healing and regeneration of the heart and explore differences 
between the adult and neonate immune system that may explain differences 
in regenerative ability.  
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1) Fibrotic repair versus regeneration – is the immune system to blame? 
Tissue injury induces a cascade of events to prevent further damage and start 
the healing process, which occurs by a variable combination of regeneration 
and fibrotic repair. While regeneration restores the original structures and 
functionality of the damaged tissue or organ, repair results in collagen 
deposition and scar formation, leading to functional impairments. The balance 
between regeneration and fibrotic repair depends on the degree of 
regenerative ability of the damaged tissue, which varies between tissues, 
species and developmental stages. While adult mammalian skin, skeletal 
muscle and liver can regenerate structure and function following damage to a 
certain degree, the adult heart has negligible capacity to regenerate.  
Overall regenerative capacity of individual species seems to decline with 
increasing evolutionary complexity. It has been suggested previously that the 
progressive complexity of the adaptive immune system in vertebrates caused 
the evolutionary loss of regeneration [1]. However, existing examples of 
efficient regeneration in mammals [2-6] indicate that the genetic basis of 
successful regeneration has been retained and may be inducible if the 
required pathways are identified. It seems that the mammalian immune 
response has evolved to favour quick repair and therefore generally 
counteracts regeneration while the immune system of lower vertebrates still 
supports regenerative repair [7-9]. This phylogenetic trend is paralleled during 
ontogeny as regenerative ability in mammals declines rapidly during early 
postnatal development. Most research on mammalian regeneration has been 
performed in rodents, whose developing embryonic hearts undergo rapid 
growth and remodelling and adjust readily to environmental insults including 
nutrient deprivation, variations in litter size, changes in blood flow, as well as 
mechanical and volume loading [10]. Compared to adults, neonatal mammals 
have a striking capacity to regenerate their hearts in several experimental 
injury models including ligation of the left anterior descending artery, apical 
resection and cryoinjury [11-15]. In one study, neonatal mice mounted a 
regenerative response that restored lost myocardial tissue and function over a 
period of 3 weeks after surgical amputation of the ventricular apex. This was 
associated with a series of cellular events reminiscent of efficient cardiac 
regeneration in lower vertebrates, including formation of a blood clot, 
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recruitment of inflammatory cells to the site of injury, epicardial cell activation, 
early extracellular matrix deposition and cardiomyocyte proliferation [13]. 
There is however substantial controversy about the degree of regenerative 
capacity, as some groups do observe fibrotic repair in neonates [16-18] and it 
seems that outcome may be sensitive to variations in experimental details 
including type and extent of injury and the way and time point of assessing 
fibrosis. While there clearly is higher regenerative capacity in the neonatal 
compared to the adult heart, it may not always be efficient enough to achieve 
full regeneration. Even in settings of successful neonatal heart regeneration in 
mice, regenerative capacity is lost shortly after birth at postnatal day 7, which 
coincides with both the developmental window when rodent cardiomyocytes 
begin to lose their proliferative potential [19, 20], but also with drastic 
alterations due to maturation of the immune system [21-23].  
Differences in regenerative capacity between developmental stages is 
especially relevant for the question whether the immune system may affect 
the outcome of healing. The mammalian immune response is quantitatively 
and qualitatively different in the neonate and adult [24-26]. Importantly, 
immune responses further change upon ageing corresponding to a 
progressive decline in regenerative ability [27]. 
Many factors have been suggested to contribute to and determine 
regenerative capacity, including environment (sterile prenatal or aquatic 
environment), the degree of tissue differentiation or the composition and 
degree of damage to the extracellular matrix. Here we speculate about the 
role of the immune system in tipping the balance between regeneration and 
fibrotic repair of the mammalian heart.  
 
2) The immune response during healing of cardiac tissue damage 
The most prevalent type of cardiac tissue injury is ischemia or 
ischemia/reperfusion following a myocardial infarct (MI). However, infections 
or autoimmune disease targeting the heart also cause cardiac tissue damage. 
The regenerative capacity of the adult mammalian heart is minimal and 
healing is achieved by fibrotic repair replacing damaged tissue with a scar. 
Quick establishment of a stable scar is important after acute damage to 
prevent fatal left ventricular rupture. However, due to its non-contractile 
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character, scar tissue impairs heart function. To compensate for prolonged 
myocardial stress, healthy structures surrounding a wounded area are 
remodelled, which may result in dilation of the left ventricle and thinning of the 
ventricle wall, eventually leading to heart failure.  
Early studies indicated that suppression of the inflammatory response 
following tissue injury may improve regeneration. However, experiments and 
clinical studies based on the idea that inflammation in general was detrimental 
to post-MI recovery used broad immunosuppression and had deleterious 
effects with enhanced adverse remodelling and increased mortality [28, 29]. 
Even broadly targeting all phagocytic cells had adverse effects. Mice depleted 
of inflammatory cells died from cardiac rupture and atherothrombosis [30] and 
MI induced in atherosclerotic mice impaired healing [31]. Importantly, healing 
in human patients is also impaired under both strongly inflammatory (chronic 
ulcers: [32], sepsis: [33]) as well as under immunosuppressed 
(corticosteroids: [34]) conditions. This demonstrates the importance of early 
inflammation and the need for a balanced and coordinated response for 
successful healing.  
 
2.1) Early events initiating the immune response 
The major cardiac resident immune cells are mast cells and macrophages, 
but small numbers of dendritic cells and lymphocytes have also been detected 
in the resting myocardium. Cells resident within the damaged tissue are 
naturally the first to be affected and respond to injury. As summarised in 
Figure 1, necrotic cell death causes the release of intracellular molecules, 
which are sensed by the complement system and surrounding cells including 
tissue resident immune cells.  
 
2.1.1) Danger Signals: 
Danger associated molecular patterns (DAMPs): As any other tissue damage, 
cardiac tissue injury causes the release of DAMPs. These can be fragments 
of extracellular matrix or intracellular molecules, which are released passively 
upon necrotic cell death including prominent examples such as heat shock 
proteins (HSPs), high-mobility group box-1 (HMGB-1) and Interleukin-33. 
DAMPs alert the immune system to damage by binding to pattern recognition 
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receptors (PRR) expressed on both immune cells and structural cardiac cells 
such as cardiomyocytes, fibroblasts and endothelial cells. Fibroblasts are 
traditionally recognised for producing and remodelling extracellular matrix 
during repair, but they also respond to immunologic stimuli and have a crucial 
part in the orchestration of the healing process [35]. PRR activation on 
fibroblasts induces their proliferation, migration, myofibroblast differentiation, 
ECM turnover and production of fibrotic and inflammatory factors [36]. 
Activated endothelial cells produce reactive oxygen species (ROS), 
inflammatory cytokines and adhesion molecules for circulating leukocytes. 
Increased vascular permeability facilitates extravasation and migration of 
leukocytes into the myocardium. Importantly, neonate endothelial cells have 
been demonstrated to express lower levels of adhesion molecules such as P-
Selectin and will therefore impair leukocyte tissue infiltration [37, 38]. 
While, due to their basic housekeeping roles, expression of DAMPs is likely 
similar in neonates and adults, they may evoke different responses in target 
cells. In humans, signalling by several Toll-like receptors (TLR), a prominent 
family of PRR, causes an IL-10, IL-6 and IL-23 dominated cytokine milieu in 
the first year of life with a parallel increase in pro-inflammatory cytokines IL-1β 
and TNF-α [39-41]. IL-10 and IL-23 are major contributors to regeneration in 
different settings. IL-10 is a potent anti-inflammatory cytokine, which plays an 
essential role in fetal regeneration. It regulates the inflammatory response, the 
extracellular matrix [42], fibroblast function and differentiation [43] and 
endothelial progenitor cell function [44]. Experimental overexpression of IL-10 
recapitulates the fetal regenerative phenotype in postnatal tissue [45, 46]. In a 
phase II clinical trial, recombinant IL-10 reduced scar formation in cutaneous 
wounds [47]. IL-23 deficiency leads to increased myocardial inflammation and 
decreased cardiac fibroblast activation, associated with impaired scar 
formation and adverse remodelling after MI [48]. IL-6 is a multifunctional 
cytokine and can have both regenerative and anti-inflammatory as well as 
pro-inflammatory activities [49]. In human infants, IL-6 has been shown to 
contribute to reduced neutrophil migration to inflammatory sites [50] which 
may be supportive of regeneration.  
TNF-α and other pro-inflammatory cytokines on the other hand contribute to 
myocardial dysfunction by directly depressing contractility and inducing 
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cardiomyocyte apoptosis [51]. It has been suggested that this dampened 
neonatal cytokine response may reduce the risk of strong immune reactions, 
which could trigger preterm birth or excessive postnatal inflammation during 
colonisation with commensal flora [52].  
 
2.1.2) Complement: Complement is an innate system of plasma- and cell 
membrane proteins which can mark (opsonise) pathogens for phagocytosis, 
augment inflammation via anaphylatoxins (C3a and C5a) and directly lyse 
target cells via the membrane attack complex (MAC) [53]. Complement 
components show distinct expression profiles in various tissues and 
developmental stages, and roles during development, stem-cell commitment 
and differentiation, reproduction as well as regeneration have been suggested 
[54]. Neutralisation of complement system components protects cardiac tissue 
from ischemia/reperfusion injury and to reduce myocardial damage in 
experimental studies [55, 56] as well as mortality after MI in clinical studies 
[57]. Notably, neonate humans have decreased levels of complement 
proteins, lower haemolytic function, and complement-mediated opsonic 
capabilities compared with adults [58, 59].  
 
Taken together, these lines of evidence suggest that the earliest stages of the 
immune response after tissue damage are already very different between 
neonates and adults, which may lead to significantly more inflammatory 
damage in the adult, while supporting regeneration in the neonate. 
 
2.2) Tissue resident innate immune cells:  
2.2.1) Mast cells: Mast cells have diverse immune functions, including quick 
release of vasoactive substances, proteases and cytokines, phagocytosis of 
pathogens and antigen presentation [60]. They are present in the heart under 
homeostasis and play important roles as earliest initiators of the wound 
healing response. Immediately after injury, they release pre-formed pro-
inflammatory and vasogenic mediators (histamines, cytokines such as TNF-α, 
proteases and growth factors) from storage granules. This initiates an 
amplification loop involving adjacent endothelial cells and fibroblasts, resident 
macrophages and subsequently, infiltrating leukocytes [61]. Mast cell 
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numbers are increased in the hearts of human patients with dilated 
cardiomyopathy [62] and after experimental MI in rats [63].  
Mast cells have been strongly implicated in inflammatory tissue damage and 
adverse remodelling after MI. At all stages of healing, infarct mast cells 
contain the proteases tryptase and chymase with potent pro-inflammatory and 
angiogenic effects. Interestingly, accumulating numbers of mast cells are 
found in areas of collagen deposition and closely associated with newly 
infiltrating monocytes and neutrophils at early stages and vascular structures 
during the healing phase in a canine model [64]. Mast cell deficient mice have 
less cardiac tissue necrosis following myocardial ischemia/reperfusion 
challenge [65] and blocking mast cell degranulation also decreased 
ischemia/reperfusion injury [66].  
Substance P has been shown to mediate adverse myocardial remodelling by 
activating cardiac mast cells, leading to increased TNF-α and matrix 
metalloproteinase (MMP) activation with subsequent degradation of the 
extracellular matrix [67]. Moreover, mast cell inhibition with cromolyn sodium 
attenuates adverse left ventricular remodelling and dysfunction in 
experimentally induced myocarditis in rats [68].  
However, there is significant controversy over the effect of mast cells on 
outcome after myocardial tissue damage as many studies made use of mice 
lacking the receptor tyrosine kinase c-Kit (Mast/stem cell growth factor 
receptor (SCFR)) as a mast cell deficient model. It is now known that c-Kit is 
expressed not only by mast cells [69] but also by differentiated and de-
differentiating cardiomyocytes [70-72]. Moreover, Kit−/− mice have additional 
immunological defects in adult T and B cell development [73], which may 
strongly impact on regenerative capacity (discussed below) and make 
interpretations drawn from studies using these mice very complicated. The 
both pro-inflammatory and angiogenic properties of mast cells as well as their 
localisation close to either infiltrating immune cells or new vessels during the 
course of myocardial healing, may suggest that comparable to macrophages 
they undergo functional changes depending on environment and are pro-
inflammatory during the early inflammatory phase and regenerative during 
later healing stages. 
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Information is limited on differences between circulating neonatal and adult 
mast cells and not available on tissue mast cells in neonates. However, 
neonatal mast cells and basophilic granulocytes isolated from the umbilical 
cord matrix and cord blood, respectively, secrete significantly more histamine 
after stimulation compared to these cells in the adult [74]. Histamine 
production by neonatal mast cells induces increased IL-10 and decreased IL-
12 expression in dendritic cells (DC) and subsequent T cell polarisation from a 
T-helper 1 (Th1) to a T-helper 2 phenotype [75]. Th2 T cells are characterised 
by expression of the signature Th2-type cytokines IL-4, IL-5 and IL-13, which 
are considered to support regeneration and counteract inflammation and 
tissue damage caused by Th1 cells and their main cytokine product IFN-γ. 
Neonatal mast cells therefore may be potent supporters of regeneration in 
neonatal mammals. 
 
2.2.2) Tissue resident macrophages: Macrophages are large immune effector 
cells specialised in recognising, engulfing and destroying target cells. DAMPs 
activate tissue resident macrophages to produce pro-inflammatory cytokines 
including TNF-α and IL-6, and chemokines such as C-X-C motif ligand 
(CXCL)1 and CXCL2, which stimulate recruitment of neutrophils [76]. 
Macrophages are the predominant immune cell population in the resting 
myocardium, and are found throughout myocardial interstitial spaces 
interacting directly with capillary endothelial cells and cardiomyocytes [77].  
By inducing cardiomyocyte cell death at varying stages of post-natal 
development using a diphtheria toxin receptor (DTR)-based genetic system, it 
was demonstrated that a resident macrophage population expands in 
neonatal hearts after damage, produces minimal inflammation and is required 
for cardiac repair through the promotion of coronary angiogenesis and 
cardiomyocyte proliferation. Strikingly, injured neonatal hearts are not 
infiltrated by significant numbers of either circulating monocytes/macrophages 
or neutrophils [78]. During homeostasis, the adult heart still contains an 
embryonically-derived macrophage population (defined as CC chemokine 
receptor 2- (CCR2-) as compared to CCR2+ macrophages originating from 
circulating adult monocytes) with similar properties. They are more efficient at 
internalising debris and engulfing apoptotic cardiomyocytes, suggesting they 
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have homeostatic roles reminiscent of the function of macrophages during 
embryonic development [79]. However, after injury, these cells are replaced or 
at least largely outnumbered by infiltrating pro-inflammatory monocytes and 
monocyte-derived macrophages, which have limited capacity to promote 
cardiac repair and generate inflammation and oxidative stress instead. 
Inhibition of recruitment of circulating monocytes into the adult heart by 
blocking CCR2, resulted in expansion of the embryonically-derived resident 
macrophage population, decreased expression of inflammatory cytokines in 
the myocardium, blocked neutrophil infiltration and enhanced coronary 
angiogenesis [78]. Even without evident injury, progressive replacement of 
resident macrophages of embryonic origin with infiltrating monocyte-derived 
macrophages over time may contribute to worsening regenerative capacity 
[80]. Resident embryonically-derived macrophages are therefore likely to have 
critical roles in the tissue-repair response [31, 78].  
Importantly, the adult tissue resident macrophage population further changes 
its functional properties with ageing. The number of expressed immune 
response genes decreases, while expression of fibrogenic genes increases. 
This is consistent with a potential role for cardiac macrophages in aging-
associated cardiac fibrosis [81].  
Thus, an age-dependent progressive loss of regenerative embryonically-
derived tissue resident macrophages, and a parallel increase of the 
inflammatory capacity of circulating and infiltrating monocytes and monocyte-
derived macrophages, strongly implicates changes of the immune system in 
changes in regenerative capacity.  
 
2.3) Infiltrating immune cells 
The vast majority of immune cells detectable in the injured myocardium are 
leukocytes infiltrating from the circulation. Damaged cardiac tissue and 
cardiac immune cells release chemoattractant molecules and activated 
endothelial cells produce adhesion molecules for circulating leukocytes. 
Increased vascular permeability facilitates extravasation and migration of 
leukocytes into the myocardium. The earliest infiltrating cell types are 
monocytes/macrophages and neutrophils, while dendritic cells, natural killer 
cells and adaptive lymphocytes appear later and in smaller numbers. Very low 
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numbers of lymphocytes are present in the myocardium under healthy 
conditions [50], while both monocytes and neutrophils are only observed 
inside capillaries but not within myocardial tissue during steady state [79]. A 
summary of differences between adult and neonate infiltrating cell types is 
shown in Figure 2.  
 
2.3.1) Monocytes/Macrophages: A recent report using endoscopic time-lapse 
imaging demonstrated that circulating monocytes appear at the site of 
damage within minutes after injury. During the initial 30 minutes after 
experimentally induced MI, the increase in monocyte numbers outpaced those 
of neutrophils, which corrects the conventional notion of neutrophils as the 
first infiltrating leukocyte cell type [82]. Inside the tissue, monocytes mature 
into macrophages which degrade macromolecules released from necrotic 
cells and aid in scavenging of dead cardiomyocytes, while mediating aspects 
of granulation tissue formation and remodelling. They are indispensible during 
wound healing and remodelling and a major source of MMPs and their 
suppressors, tissue inhibitors of MMPs (TIMPs). A changing chemokine 
expression profile in the infarcted area over time, leads to a sequential 
dominance of Ly-6C(hi) and Ly-6C(lo) tissue macrophages in mice. Ly-6C(hi) 
macrophages dominate early after damage and have mainly phagocytic, 
proteolytic, and inflammatory functions due to their expression of inflammatory 
cytokines (TNF-α, IL-1β) and proteases (cathepsin, urokinase). Ly-6C(lo) 
macrophages dominate after around 3 days after injury. They have anti-
inflammatory properties (IL-10, TGF-β), and express Vascular Endothelial Cell 
Growth Factor (VEGF) and MMP 9, by which they promote healing via 
myofibroblast accumulation, angiogenesis and deposition of collagen [31]. 
However, macrophage production of MMP 9 and TGF-β are considered 
significant pro-fibrotic factors and inhibition of either can reduce fibrosis in 
models of myocardial infarction [83] and pressure overload [84], respectively. 
Initially this biphasic response was considered to be due to infiltration of the 
corresponding Ly-6C(hi) and Ly-6C(lo) monocyte subsets circulating the 
peripheral blood, which differentiated into macrophages once inside the 
cardiac tissue. Importantly, these two populations correspond to circulating 
CD14+CD16- and CD14+CD16+ monocytes in humans, which also infiltrate 
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infarcted hearts early and late, respectively [85, 86]. However, recently it has 
been suggested that anti-inflammatory Ly-6C(lo) actually derive from Ly-
6C(hi) cells, which display high plasticity and develop into either pro-
inflammatory or anti-inflammatory macrophages depending on the respective 
environment [87]. Independent of their origin, the biphasic change in 
macrophage phenotype and function and an appropriate balance between the 
two subsets is now accepted to be crucial for efficient healing early after MI as 
well as a potential target to improve regeneration and inhibit adverse 
remodeling.  
A recent study identified a number of qualitative and quantitative differences 
in the cellular immune response of efficiently regenerating 1-day-old and non-
regenerative 14-day-old mice following myocardial infarction. Importantly, an 
increased abundance of macrophages and a difference in macrophage 
localisation was observed and depletion of macrophages using clodronate 
liposomes in neonatal mice blocked heart regeneration following MI [88]. As 
infiltration of circulating monocytes/macrophages is negligible in neonatal 
hearts, regeneration is largely mediated by the embryonically-derived resident 
macrophage population [78] which play a crucial role in regenerative 
processes and are required for neonatal heart regeneration.  
 
2.3.2) Neutrophils: Neutrophils are attracted by DAMPs and early 
cytokines/chemokines produced by macrophages in the damaged tissue. 
They are the dominant cell type 24h after injury in terms of total numbers and 
play a central role in augmenting and shaping early inflammatory responses 
as they degrade necrotic tissue and recruit and activate macrophages to 
remove the debris. Neutrophils contain granules pre-loaded with effector 
molecules (azurocidin, cathelicidin, antimicrobial peptide LL-37 and cathepsin 
G) and produce additional IL-6, which recruits monocytes and activates 
endothelial cells [89, 90]. In addition, upon activation neutrophils undergo 
‘netosis’, a form of cell death associated with release of decondensed 
chromatin including histones and proteases, a structure termed neutrophil 
extracellular traps (NETs). While NETs are effective in trapping and killing 
bacteria, they also are cytotoxic and thrombogenic [91]. Activated neutrophils 
then undergo apoptosis within a few hours and serve as additional attractant 
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for infiltrating monocytes, while inhibiting additional influx of neutrophils [92], 
which explains the brief window of neutrophil accumulation right after injury.  
Several neutrophil-related measures in peripheral blood have been shown to 
correlate with prognosis and remodelling after acute myocardial infarct. 
Peripheral neutrophil count and neutrophil/lymphocyte ratio predict adverse 
prognosis and remodelling after acute MI [93, 94]. Granule contents of 
neutrophils such as myeloperoxidase (MPO) [95] and proteinase 3 [96] can be 
used as markers for long-term mortality in MI patients.  
These studies suggest that excessive neutrophil activation is detrimental after 
MI. However, targeting neutrophils in animal and clinical studies has resulted 
in contradicting outcomes. MMP 8 and 9, which are produced by neutrophils 
and degrade extracellular matrix, are elevated in patients with left ventricular 
rupture after MI [97] and inhibition of MMP 9 in mice attenuated left ventricular 
dilation and collagen accumulation [83] and promoted angiogenesis [98]. 
Antibody-dependent inhibition of L-Selectin and P-Selectin to block neutrophil 
influx, lowered neutrophil accumulation and reduced necrosis after 
reperfusion [99], while P-Selectin knockout mice did not show any differences 
in tissue damage despite a reduction in leukocyte accumulation [100]. Finally, 
animal experiments using antibody-dependent blocking of the CD11/CD18 
integrin showed a very promising improvement of left ventricular function after 
ischemia/reperfusion damage [101]. However, the corresponding human 
antibody that was subsequently used in clinical studies, showed no effect 
[102]. Thus, although dampening the neutrophil response may be beneficial 
after MI, we still don’t understand all the factors involved well enough to 
translate experimental findings into successful clinical trials. 
Strikingly, in stark contrast to adults and in line with impaired neutrophil 
migration, negligible neutrophil numbers seem to infiltrate neonatal mouse 
hearts after DTR-induced cardiomyocyte death, which may strongly impact on 
intensity of inflammation and inflammatory tissue damage [78]. Significant 
functional differences between adult and neonate neutrophils may also 
account for enhanced neonatal regeneration. Human newborns have less 
neutrophils with significantly impaired function due to lower expression of 
activating TLR [103] and low levels of cell surface L-selectin and Mac-1 
(CD11b/CD18) [104] leading to a 50% reduction in adhesion to endothelial 
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cells and transmigration into tissue. The IL-6 dominated cytokine milieu in the 
first year of life further contributes to reduced neutrophil migration to 
inflammatory sites [50].  
In summary, there is convincing evidence that neutrophil induced 
inflammatory damage is detrimental after cardiac tissue damage. The 
impaired function of neonate neutrophils may be sufficient to support the 
initiation of the healing response but protect from excessive damage to allow 
quicker resolution of inflammation and more efficient regeneration. 
 
2.3.3) Natural Killer cells (NK): NK cells are members of a highly 
heterogeneous population of innate lymphoid cells (ILC) that closely mirror 
subsets of adaptive T-lymphocyte in terms of cytokine production [105]. NK 
cells have been suggested to present the innate counterparts of cytotoxic 
CD8+ T cells and rapidly express effector cytokines such as TNF-α and IFN-γ 
[106]. Despite their expression of TNF-α and IFN-γ, NK cells infiltrating the 
heart after MI may have the ability to improve regeneration as adoptive 
transfer of IL-2-activated NK cells and injection of recombinant IL-2 promote 
angiogenesis and improve cardiac function following infarction [107]. In line 
with this concept, a reduced NK cell activity in patients with coronary artery 
disease in comparison to healthy subjects has been described [108, 109]. NK 
cells are more abundant in peripheral blood of newborns than in adults [110]. 
Considering that NK cells are beneficial during regeneration, a higher number 
in neonates may provide additional support for the neonatal regenerative 
capacity. 
 
2.3.4) Dendritic cells: DC are the link between innate and adaptive immune 
response as they are professional antigen presenting cells (APC), which can 
process and present antigens in a T cell-recognisable form and thereby 
initiate adaptive immune responses.  
Small numbers of dendritic cells are present in cardiac tissue, some of which 
are localised in cardiac valves, where they have been suggested to monitor 
for non-self antigens [79, 111]. Additional infiltration of dendritic cells into 
infarcted areas of rat hearts after experimental MI has been demonstrated. 
Depletion of bone marrow-derived DC exacerbated post-infarct left ventricular 
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remodelling and was associated with enhanced inflammatory cytokine 
expression, MMP 9 activation and infiltration of pro-inflammatory Ly-6c(hi) 
monocytes/macrophages into the infarcted myocardium [112].  
These findings suggest that DC play a protective role against post-infarction 
left ventricular remodelling by regulating the homeostasis of monocytes and 
macrophages during the transition from inflammation to repair. The same 
group showed that decreased numbers of DC in human infarcted myocardial 
tissue were associated with increased macrophage infiltration, impaired 
reparative fibrosis, and the development of cardiac rupture after MI. Thus, DC 
modulate post-MI inflammation and the subsequent healing process [113]. 
In human newborns, DC express lower MHC-II, CD80 and CD86 compared to 
adult cells indicating their inability to fully activate antigen-specific T- and B 
cell responses [114-116]. TLR stimulation of whole blood from human infants 
produces elevated levels of IL-10, IL-6 and IL-23 which creates a regenerative 
cytokine environment [50]. This lowered expression of co-stimulatory 
molecules and a bias against Th1-type cytokines such as IFN-γ may aid 
regenerative processes.  
 
2.3.5) Adaptive Lymphocytes: Circulating lymphocytes comprise T- and B 
cells, with several subpopulations defined by surface marker expression and 
function. T cells are divided in two main subsets, CD8+ T cells with the ability 
to directly lyse target cells, and CD4+ T cells, which are major cytokine 
producers and thereby define and orchestrate immune responses. A 
simplified classification usually defines CD4+ T cells as Th1 (IFN-γ, IL-2 and 
TNF-α), Th2 (IL-4, IL-5, IL-13), Th17 (IL-17, IL-21, and IL-22) or regulatory T 
(Treg) cells (TGF-β, IL-35). Importantly, all these cells produce IL-10 when 
activated, which demonstrates its crucial role as a feedback regulator of 
inflammation.  
CD4+ T cells: CD4+ T cells are present in the myocardium under healthy 
conditions and additional numbers of a primarily Th1 phenotype are recruited 
after myocardial infarct [50]. Activation of T cells after MI requires an intact 
TCR repertoire for self-antigen recognition and activated T cells are therefore 
auto-reactive [117]. Importantly, increased levels of α-MyHC antibodies can 
be detected in patients with dilated cardiomyopathy and after MI [118, 119]. 
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Due to a gap in central tolerance, T cells specific to α-MyHC are also present 
in peripheral blood of healthy donors. However, under steady state, tolerance 
to α-MyHC is maintained through unknown peripheral mechanisms, but 
additional co-stimulatory signals, such as local or systemic inflammation, 
might be able to break tolerance and induce autoimmunity against this 
myocardial antigen. Other auto-antibodies against a variety of cardiomyocyte 
proteins are also detected in heart disease [120]. This aspect of adaptive 
immunity after MI is very relevant to the question whether the adult 
mammalian immune system prevents regeneration. Autoimmune tissue 
damage with its negative impact on regeneration is only possible in the 
presence of a fully functional and matured adaptive immune system. While 
both evolutionarily older vertebrates and neonatal mammals have adaptive 
immune systems, they are either comparably inefficient or immature, which 
may prevent this aberrant autoimmune response. 
While a protective role has recently been suggested for the whole CD4+ T cell 
population including Treg cells [117], there is evidence that CD4+ T effector 
cells only contribute to early myocardial injury in an ischemia/reperfusion 
situation via their production of IFN-γ [121, 122] as well as to fibrosis durig 
healing through production of IL-13 and IL-4 [123]. This may indicate that a 
protective role of the total CD4+ T cell population is due to Treg cells. Treg 
cells are potent suppressor cells, which have essential functions in 
preventing, limiting and resolving inflammation. By producing the major 
immunosuppressive cytokines IL-10, TGF-β and IL-35 they affect all known 
immune cell types and are therefore considered upstream regulators of 
immune responses. A small number of regulatory T cells is detectable in adult 
cardiac tissue under homeostasis [124] and Treg cells are considered 
beneficial after MI. Expanding Treg cell numbers in vivo by adoptive transfer 
or administration of CD28-superagonistic antibody attenuates expression of 
pro-inflammatory cytokines and immune cell infiltration in the myocardium 
post-MI and most importantly ameliorates adverse remodelling [125, 126]. 
Treg cells promote monocyte differentiation into regenerative macrophages in 
the myocardium, which is associated with increased collagen de novo 
expression within the scar, resulting in decreased rates of left ventricular 
rupture. Conversely, depletion of Treg cells accelerates left ventricular dilation 
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and impairs survival after MI with increased neutrophil numbers and elevated 
numbers of inflammatory Ly-6C(hi) macrophages in the infarct zone [127]. An 
independent study confirms these results and shows in addition that Treg 
cells modulate the cardiac fibroblast phenotype, reducing expression of α-
smooth muscle actin, decreasing expression of MMP 3 and attenuating 
contraction of fibroblast-populated collagen pads. This suggests that Treg 
cells exert anti-inflammatory and matrix-preserving properties after MI that 
may attenuate adverse post-infarction remodelling [124]. They therefore seem 
an excellent candidate for a central role in regulating fibrosis and regeneration 
and a very promising therapeutic target to improve cardiac repair.  
Treg cells are present in higher frequency in human cord blood and neonatal 
lymph nodes compared to adult tissues [128, 129]. High fetal Treg cell 
numbers reflect a strong tendency of naive fetal T cells to differentiate into 
Treg cells in response to maternal antigens that cross the placenta [130]. 
Human neonatal naive T cells also have an intrinsic default mechanism to 
differentiate into Treg cells in response to TCR stimulation [131] and neonatal 
CD4+ helper T cells are polarised towards regenerative Th2 responses (IL-4, 
IL-5, IL-10, IL-13), with a decreased production of Th1 cytokines (IFN-γ, IL-2 
and TNF-α) [132]. 
B lymphocytes: A small number of B cells is present in cardiac tissue under 
resting conditions [133]. B cell numbers in the myocardium increase after 
infarct. Their surface marker phenotype indicates that MI triggers the 
infiltration of circulating mature B cells [134]. Genetic or antibody-mediated 
depletion of B cells is beneficial after MI, leading to reduced levels of the 
chemokine (C-C motif) ligand 7 (CCL7) and lower pro-inflammatory Ly-6C(hi) 
monocyte infiltration, decreased infarct size, lessened left ventricular dilation 
and improved recovery of left ventricular function [133]. In contrast an earlier 
study showed that intra-myocardial injection of immature bone marrow–
derived B cells after acute myocardial infarction in rats improved the recovery 
of myocardial function [135]. While this may present a valuable therapeutic 
option, it is likely not relevant under physiological conditions as immature 
bone marrow–derived B cells won’t reach the infarcted myocardium. Neonatal 
B cells are naive, lack antigenic exposure and have only a partially developed 
surface immunoglobulin repertoire [136]. This may reduce their ability to 
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produce efficient antibodies and may be beneficial during regeneration, where 
auto-antibodies are detrimental. 
 
3.) Summary and conclusion 
From the studies cited in this review, it is clear that the immune system has a 
causative role to play in the decline of regenerative capacity with age. We 
have summarised available data on the adult and neonate immune system 
and the many intriguing differences that correlate with loss of regenerative 
capacity. While most cell types characterised in the adult mammal have also 
been identified in the neonate, there is a clear predominance of responses 
governed by the innate immune system with less inflammation and improved 
regenerative responses. The mature immune system generates strong 
inflammatory reactions in response to DAMPs, which are characterised by 
prototype Th1 pro-inflammatory cytokines, as well as a strong fibrotic 
response characterised by Th2 cytokines during healing. This will cause 
severe tissue damage early after cardiac injury and lead to excessive fibrosis 
instead of regenerative healing. 
Neonates generate less early inflammation after tissue damage due to 
deficiencies in leukocyte infiltration and an anti-inflammatory and regulatory 
cytokine milieu under the strong influence of regulatory IL-10. Importantly, 
activation of the adaptive immune system against cardiac self-proteins causes 
autoimmune damage and can impair regeneration in the adult, while 
lymphocytes are immature and prone to developing into regulatory cells in the 
neonate. Taken together, it seems that the adult (albeit young and healthy) 
mammalian immune response creates an environment that favours quick 
repair by fibrosis over regenerative healing. From an evolutionary perspective, 
this attribute has conveyed an obvious survival advantage during a time 
where quick closing of skin wounds was a significantly more pressing problem 
than recovering from a heart attack. In modern society with antibiotics 
available to fight infection resulting in an aging population suffering from heart 
disease, this ancient survival mechanism has turned against us. 
The comparably weak immune system of neonates on the other hand seems 
to support regeneration. Less inflammatory damage early on and a more 
balanced fibrotic response allow for a better outcome of healing (figure 3). 
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These aspects of the immune system in human newborns and infants have 
received a great deal of attention as they impair defences against early 
infections, make infants significantly more prone to allergies and have 
important implications when designing vaccinations for children. However, the 
same insufficiencies may be the key to activating the immune cascade and 
healing response, while avoiding the excessive and ongoing inflammatory 
tissue damage caused in the adult. 
It is increasingly appreciated that the immune system is more than a mere 
defence machinery against infections, but has an array of roles during 
reproduction, development and tissue homeostasis. In addition, looking at the 
immune system as one entity is a vast over-simplification, which has already 
brought several clinical trials using broad immunosuppression to a 
disappointing end. The immune system comprises countless cell types and 
effector molecules with pleiotropic and synergistic or antagonistic effects, 
which may even change in individual cells depending on environment and 
circumstances. Although we have already accumulated a vast body of 
knowledge on the immune response after cardiac tissue damage, it is still 
insufficient for a full understanding of the whole network of immune cells and 
their mediators to allow appropriate intervention to boost full functional 
recovery and regeneration. Importantly, relative levels of mediators and their 
temporal and spatial regulation are likely to impact strongly on regenerative 
outcome. This makes therapeutic strategies that dampen specific detrimental 
effects of the immune system, while boosting the regulatory and regenerative 
arm, the primary clinical challenge towards cardiac healing and regeneration.  
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5.) Figure legends  
 
Figure 1: Cells and factors involved in the early steps of the immune 
response to cardiac tissue damage and differences between adult and 
neonate.  
 
Figure 2: Differences between adult and neonate immune cells infiltrating the 
myocardium in response to damage and inflammatory stimulation. 
 
Figure 3: The mature immune system of the adult mammal causes strong 
inflammation characterised by cytokines such as TNF-α, IL-1, and IFN-γ at 
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early stages after injury as well as a strong fibrotic response characterised by 
IL-4, IL-5, IL-13 and TGF-β during the healing phase. The comparably weak 
immune system in the neonate expresses high levels of IL-10 and results in 
dampened responses in both inflammatory and regenerative phase, which 
causes less damage and fibrosis and allows for a better regenerative 
outcome.  
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Highlights: 
 Regenerative capacity of the mammalian heart decreases rapidly during 
post-natal development. 
 Loss of regeneration correlates with maturation of the immune system. 
 Strong inflammatory and fibrotic responses damage the tissue and lead to 
scar formation in adults. 
 The immature and weak immune system of neonates causes a balanced 
regenerative response instead. 
